Zacks Investment Research upgraded shares of MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (NYSEARCA:MOR) from a hold rating to a buy rating in a report published on Saturday morning. They currently have $31.00 target price on the stock.

According to Zacks, “MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company’s proprietary portfolio consists of MOR208, MOR202, MOR103, MOR106 and MOR107. Its partnered programs lighthouse project includes Tremfya(R) and Gantenerumab. MorphoSys AG is based in Planegg, Germany. “

Several other research firms have also weighed in on MOR. JPMorgan Chase & Co. boosted their price objective on shares of MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 from $32.00 to $34.00 and gave the stock an overweight rating in a research note on Wednesday, November 14th. Piper Jaffray Companies started coverage on shares of MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 in a research note on Monday, November 5th. They set an overweight rating and a $38.00 price objective on the stock. Deutsche Bank lowered shares of MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 from a buy rating to a hold rating in a research note on Monday, July 30th. Finally, Berenberg Bank lowered shares of MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 from a buy rating to a hold rating in a research note on Friday, September 7th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 presently has an average rating of Buy and a consensus price target of $35.25.

Shares of MOR stock opened at $27.73 on Friday. MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 has a 1 year low of $21.75 and a 1 year high of $35.90.

Featured Story: Price to Earnings Ratio (PE) Basics

Get a free copy of the Zacks research report on MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (MOR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (NYSEARCA:MOR)

Receive News & Ratings for MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 and related companies with MarketBeat.com's FREE daily email newsletter.